Cholesterol Synthesis Inhibitors Do Not Reduce Lp(A) Levels in Normocholesterolemic Patients

Author： Pazzucconi F.   Franceschini G.   Gianfranceschi G.   Campagnoli G.   Sirtori C.R.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.34, Iss.3, 1996-09, pp. : 131-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 1, 2008-01 ,pp. : 39-42

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 424-427

Bentham Science Publishers

Access to resources Recommend Favorite

Do ACE Inhibitors/Angiotensin II Type 1 Receptor Antagonists Reduce Hospitalisations in Older Patients with Heart Failure?: A Propensity Analysis

By Trewet CoraLynn B.   Shireman Theresa I.   Rigler Sally K.   Howard Patricia A.  

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 945-955

Adis International

Access to resources Recommend Favorite

ACE inhibitors reduce CV risk in patients with atherosclerosis

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Synthesis and Bioactivities of 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors

By  

Medicinal Chemistry, Vol. 7, Iss. 6, 2011-11 ,pp. : 534-542

Bentham Science Publishers

Access to resources Recommend Favorite